Brief: Spectral Medical To Launch Toraymyxin/EAA In Canada In Q1 2018
13/12/2017 13:01
Dec 13 (Reuters) - Spectral Medical Inc EDT.TO :
* SPECTRAL MEDICAL TO LAUNCH TORAYMYXIN/EAA IN CANADA IN Q1
2018
* SPECTRAL MEDICAL INC - ENTERED DISTRIBUTION AGREEMENT WITH
CASTER MEDICAL SYSTEM TO LAUNCH TORAYMYXIN AND EAA IN CANADA
COMMENCING IN Q1 OF 2018
Source text for Eikon: ID:nMKWV7RLTa
Further company coverage: EDT.TO
((bangalore.newsroom@thomsonreuters.com;))
Recent news on Spectral Medical
See all newsBrief: Spectral Medical Provides Update Following In-Person FDA 100-Day Meeting For PMX PMA
Canada's Spectral Medical Q2 revenue falls on lower reagent sales
Brief: Spectral Medical And Vantive Announce Topline 12 Month Follow-Up Results From Spectral’S Tigris Trial
Canada's Spectral Medical Q1 revenue rises 56%, net loss narrows
Spectral Medical Q3 revenue up 34%